U forgot Lambda Variant and Delta Plus Variant!
COVID is here to stay and not going anywhere with more deadlier variants on the horizon is my opinion.
If Escozine is what it is set to be then their might be a really good chance it might have something to say in the next few months to a year.
The only thing in my opinion that is keeping QNTA from going where it deserves to go is the dilution/conversions. The million dollar question is how much longer??????)))
The approval from DR in my opinion will set this on fire ?? as well. The other million dollar question is when???????
South America is suffering from the Lambda Variant and their cases apparently are pretty high and not dropping much.
UK yesterday and today had over 32000 COVID cases. We all know it takes a few weeks for the death rates to increase to catch up with today’s high infection numbers. God only knows how bad these death rates will be in a month!
Israel is reporting that Pfizer efficacy has dropped from the 90’s to the 60’s and if I understood the article well that means efficacy drops day after day meaning the world population will be needing booster shots on an on going basis, I would assume at least 2-3 times a year to keep efficacy in the 90’s and minimise the seriousness of the disease especially death rates.
COVID will be worse than the regular flu ppl. It’s apparently not as seasonal as ppl think it is, yes it peaks in the fall and winter, but as we can all see the numbers in certain countries in the Middle East where it is 50 degrees Celsius the numbers are still the same, in the UK with 32000 infections where it is summer time, the last time these numbers where seen was back in January!!
What matters to me is where Medolife is going to be in all this come winter time!!! How quickly if anything they can go through clinical trials if it becomes a state of emergency with all these new variants popping up now! How effective is Escozine with these variants and as a secondary booster to these existing vaccines from the likes of Pfizer, Moderna etc,.
Lots of good potential for Medolife especially Escozine if only the dilution/conversions can stop, and the company does what it says it’s going to do, name and ticker change, Tony Hawk, and the news from the DR is something I believe personally will reverse this completely once news comes out. Dilution/conversions needs to stop no matter what.
Time will tell.
Have a great evening all.
